-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Patients with pre- stroke mobility impairment (PSMI) were excluded from intravascular clinical trials
.
There are very limited data on the safety and outcome of intravascular thrombectomy in this population
Stroke blood clot
Recently, a research article was published in Stroke, an authoritative journal in the field of cardiovascular disease.
Researchers used a large national data set to evaluate the safety and outcome of intravascular thrombectomy in patients with PSMI
.
The researchers included patients who underwent endovascular thrombectomy between 2015 and 2019
.
PSMI is defined as the inability to walk independently
Although the incidence of adverse surgical outcomes in PSMI patients has not increased, further research is needed to determine the clinical benefit of this population
Original source:
Rachel Beekman.
et al.
Outcomes of Endovascular Therapy in Patients With Prestroke Mobility Impairment .
stroke.
2021.